26.54
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Harmony Biosciences Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Does Harmony Biosciences Holdings Inc. show high probability of reboundGlobal Markets & Technical Buy Zone Confirmations - newser.com
Can Harmony Biosciences Holdings Inc. hit a new high this monthJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Using AI based signals to follow Harmony Biosciences Holdings Inc.July 2025 News Drivers & Daily Technical Forecast Reports - newser.com
Harmony Biosciences Hits 52-Week Low at $26.15 Amid Market Turbulence - Markets Mojo
Custom watchlist performance reports with Harmony Biosciences Holdings Inc.Inflation Watch & Community Shared Stock Ideas - newser.com
Harmony Biosciences stock hits 52-week low at $26.26 By Investing.com - Investing.com Nigeria
What analysts say about Harmony Biosciences Holdings Inc stockEarnings Volatility Patterns & Amplify Gains With Picks - earlytimes.in
Harmony Biosciences (NASDAQ:HRMY) Hits New 1-Year LowWhat's Next? - MarketBeat
Robeco Institutional Asset Management B.V. Takes $1.48 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Top 3 Health Care Stocks That Are Preparing To Pump In Q4 - Sahm
Harmony Biosciences Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now? - MSN
Using Bollinger Bands to evaluate Harmony Biosciences Holdings Inc.Weekly Trade Report & Weekly Breakout Watchlists - newser.com
Understanding Harmony Biosciences Holdings Inc.’s price movementOil Prices & Low Drawdown Investment Strategies - newser.com
What drives Harmony Biosciences Holdings Inc stock priceSector Leadership Analysis & Master Stock Selection - earlytimes.in
Harmony Biosciences’ Fragile X Trial Falls Short but Offers Key Insights - MyChesCo
Exit strategy if you’re trapped in Harmony Biosciences Holdings Inc.July 2025 Trends & Stock Portfolio Risk Management - newser.com
Harmony Biosciences Hits New 52-Week Low at $26.26 - Markets Mojo
Harmony Biosciences (HRMY): Assessing Valuation After RECONNECT Trial Disappointment for ZYN002 in Fragile X Syndrome - Yahoo Finance
H.C. Wainwright Reaffirms Buy on Harmony Biosciences Holdings, Inc. (HRMY) Despite Phase 3 Setback - MSN
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates - MSN
10 Best Low Priced Growth Stocks to Buy Now - Insider Monkey
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of “Buy” from Analysts - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Q3 EPS Estimate for Harmony Biosciences Boosted by Analyst - MarketBeat
Wall Street Zen Downgrades Harmony Biosciences (NASDAQ:HRMY) to Hold - MarketBeat
Harmony Biosciences Holdings Inc Stock Analysis and ForecastAutomated Trading Signals & Free Trend Following Techniques - Early Times
Harmony Biosciences Hits 52-Week Low at $26.35 Amid Market Struggles - Markets Mojo
HC Wainwright Has Positive Estimate for HRMY Q2 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Medtronic (MDT) - The Globe and Mail
Harmony Biosciences (NASDAQ:HRMY) Given New $35.00 Price Target at Mizuho - Defense World
Mizuho lowers Harmony Biosciences stock price target to $35 after trial setback By Investing.com - Investing.com Nigeria
Mizuho lowers Harmony Biosciences stock price target to $35 after trial setback - Investing.com Canada
Harmony Biosciences stock price target lowered to $55 at H.C. Wainwright - Investing.com Australia
Harmony Biosciences stock price target lowered to $55 at H.C. Wainwright By Investing.com - Investing.com South Africa
Deutsche Bank Maintains Harmony Biosciences Holdings (HRMY) Buy Recommendation - Nasdaq
Harmony Biosciences Hits Day Low of $26.61 Amid Price Pressure - Markets Mojo
Harmony Biosciences: Cannabinoid Fragile X Fail Merits Rating Downgrade (NASDAQ:HRMY) - Seeking Alpha
Mizuho Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):